Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reversal of Opioid-induced Respiratory Depression With Opioid Antagonists - a Study in Opioid naïve Individuals and Chronic Opioid Users Under Real-life Conditions

NCT05338632 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT05338632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05338632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reversal of Opioid-induced Respiratory Depression With Opioid Antagonists - a Study in Opioid naïve Individuals and Chronic Opioid Users Under Real-life Conditions
Lead sponsor
Leiden University Medical Center
Phase
Phase 1
Overall status
Terminated
Start date
June 24, 2022
Completion date
March 23, 2026
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic opioid use, opioid induced respiratory depression